Search Results

You are looking at 1 - 4 of 4 items for :

  • Gemcitabine x
Clear All
Open access

Angelo Paci, Ségolène Hescot, Atmane Seck, Christel Jublanc, Lionel Mercier, Delphine Vezzosi, Delphine Drui, Marcus Quinkler, Martin Fassnacht, Eric Bruckert, Marc Lombès, Sophie Leboulleux, Sophie Broutin and Eric Baudin

stable disease at the time of gemcitabine-based chemotherapy sequence as indicated in Fig. 1 . Surprisingly, no single-grade 2–4 neurological adverse event was observed according to the National Cancer Institute Common Terminology Criteria for Adverse

Open access

Maura Bucciarelli, Ya-Yu Lee and Vasudev Magaji

patient's re-biopsy was 10% ER positive, the patient was started on tamoxifen and completed nine cycles of gemcitabine/carboplatin. Her lower cortisol levels allowed de-escalation of the metyrapone dose to 500 mg p.o. every 6 h and provided useful

Open access

S Solomou, R Khan, D Propper, D Berney and M Druce

and bony sites from the start of chemotherapy until March 2013. He developed an increasing burden of disease in the liver at this point and therefore commenced gemcitabine–carboplatin chemotherapy, receiving five cycles with palliative intention

Open access

Ali A Zaied, Halis K Akturk, Richard W Joseph and Augustine S Lee

M Hodgkin lymphoma NR NR NR GAD65 COPP, brentuximab, gemcitabine, ICE NR NR  This case 70 M RCC DKA 6 weeks 8.4 None None No No Pembrolizumab  ( 19 ) 64 F Melanoma Hyperglycemia <1 month